Genentech vet sets up deal-making shop

20-year Genentech veteran Suzy Jones has left the biotech giant to set up her own shop helping small biotechs negotiate drug deals with the big boys in the biopharma industry. Jones says that DNA Ink already has two clients on board and is close to signing deals with more. There's so much good science out there and there are buyers," Jones told the San Francisco Business Times. "We'll do great deals and we'll do them quickly." Story

Suggested Articles

Minerva's seltorexant helped patients fall asleep more quickly and stay asleep for longer, beating placebo and Sanofi’s Ambien in a phase 2b study.

Cannabidiol might work as a powerful antibiotic against certain drug-resistant bacteria such as methicillin-resistant S. aureus.

Krystal Biotech posted data from a phase 2 study showing its topical gene therapy closed the majority of wounds in patients with a rare skin disorder.